$1.55
At close: May 1 EDT
$1.50
-0.05-3.23%
Pre-Market: 7:21 PM EDT
Comments
Loading...
TScan Therapeutics Stock Guidance | NASDAQ:TCRX | Benzinga
TScan Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TScan Therapeutics Inc (TCRX) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for TScan Therapeutics (TCRX)?
There have been no specific sales or earnings guidance reported for TScan Therapeutics in recent months.
Browse guidance and forecast on all stocks.
